Dr. Licht is the Johanna Dobe Professor of Medicine, Chief, Division of Hematology/Oncology and Associate Director for Clinical Sciences of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Dr. Licht received his M.D. from Columbia University and trained in medical oncology and molecular biology at the Dana-Farber Cancer Institute. From 1991-2006 he served on the faculty at the Mount Sinai School of Medicine in the Departments of Medicine and Molecular Biology, where he rose to the rank of Professor and Associate Dean for Cancer Programs.
Dr. Licht's laboratory studies aberrant transcriptional repression as a cause of hematological malignancy, including acute promyelocytic leukemia and multiple myeloma, and is exploring multiple strategies to reverse this repression. Dr. Licht, formerly a Leukemia Society Scholar, and recipient of a Buroughs Wellcome Clinical Scientist Award in Translational Research is currently the Principal Investigator of a Leukemia and Lymphoma Society Specialized Center of Excellence grant, studying epigenetic mechanisms in hematological malignancy. Dr. Licht is a Senior Editor of Clinical Cancer Research and serves on the editorial boards of Cancer Research and Oncogene. Dr. Licht served as a Councilor of the American Society for Clinical Investigation a member of the Association of American Physicians.
Departments of Medicine and Molecular Biology, and was awarded the titles of professor, chief of Hematology/Oncology, and associate dean for cancer programs. His laboratory focuses on the study of aberrant transcriptional repression as a cause of hematological malignancy (including acute promyelocytic leukemia and multiple myeloma) and has utilized small molecules and peptide interference strategies to reverse this repression.